XML 193 R24.htm IDEA: XBRL DOCUMENT v3.20.1

Non-Controlling Interests

12 Months Ended

Dec. 31, 2019

Non-Controlling Interests

Non-Controlling Interests

(18)    Non-Controlling Interests

Details of non-controlling interests and movement at 31 December 2018 are as follows:

		Thousands of Euros
								Business
								Combination /
								Additions to
		Balance at						Consolidated		Translation		Balance at
		31/12/2017		Additions		Disposals		Group		differences		31/12/2018
Grifols (Thailand) Pte Ltd		3,579		193		(43)		—		206		3,935
Grifols Malaysia Sdn Bhd		1,372		326		—		—		37		1,735
Araclon Biotech, S.A.		(1,477)		(2,011)		—		—		—		(3,488)
Progenika Biopharma, S.A.		880		—		(871)		—		—		9
VCN Bioscience, S.L		421		(281)		—		—		—		140
Kiro Grifols , S.L.		111		(463)		—		—		—		(352)
Haema AG		—		—		—		220,190		—		220,190
Biotest US Corporation		—		—		—		249,691		(810)		248,881
		4,886		(2,236)		(914)		469,881		(567)		471,050

Details of non-controlling interests and movement at 31 December 2019 are as follows:

		Thousands of Euros
		Balance at								Translation		Balance at
		31/12/2018		Additions		Disposals		Capital increases		differences		31/12/2019
Grifols (Thailand) Pte Ltd		3,935		193		—		—		421		4,549
Grifols Malaysia Sdn Bhd		1,735		380		—		—		56		2,171
Araclon Biotech, S.A.		(3,488)		(1,975)		—		5,892		—		429
Progenika Biopharma, S.A.		9		0		(9)		—		—		—
VCN Bioscience, S.L		140		(292)		—		—		—		(152)
Kiro Grifols , S.L.		(352)		(374)		—		750		—		24
Haema AG		220,190		5,881		—		—		—		226,071
Biotest US Corporation		248,881		19,685		—		—		11,444		280,010
Grifols Diagnostic Solutions, Inc. (see note 2)		—		1,510,547		—		—		—		1,510,547
		471,050		1,534,045		(9)		6,642		11,921		2,023,649

At 31 December 2019, the summary financial information on the non-controlling interests of Haema AG and Biotest US Corporation, is as follows:

		Thousands of Euros				Thousands of Euros
		31/12/2019				31/12/2018
		Haema AG		Biotest US Corp		Haema AG		Biotest US Corp
Non-current assets		244,107		299,045		199,056		215,072
Current assets		32,576		60,099		19,527		40,352
Total Assets		276,683		359,144		218,583		255,424
Non-current liabilities		22,226		56,425		98		8,766
Current liabilities		28,386		22,709		(1,705)		(2,223)
Total Liabilities		50,612		79,134		(1,607)		6,543
Total equity		226,071		280,010		220,190		248,881

At 31 December 2019, the summary financial information on the non-controlling interests of GDS Group is as follows:

		Thousands of Euros		Thousands of USD
		31/12/2019		31/12/2019
Non-current assets		3,416,366		3,834,871
Current assets		273,259		306,734
Total Assets		3,689,625		4,141,605
Non-current liabilities		224,635		252,153
Current liabilities		108,220		121,478
Total Liabilities		332,855		373,631
Total equity		3,356,770		3,767,974

X

- Definition

Non-controlling Interests [abstract]

+ References

No definition available.

+ Details

Name:	grfs_NonControllingInterestsAbstract
Namespace Prefix:	grfs_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of non-controlling interests. [Refer: Non-controlling interests]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2019-01-01
-Paragraph 10
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2019-03-27

+ Details

Name:	ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration